author-photo

Vanessa Bolejack

University of Arkansas for Medical Sciences

3

Papers

52

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Total Therapies (TT) for Newly Diagnosed Patients with Multiple Myeloma (MM): Significant Benefit in High-Risk Disease with Cytogenetic Abnormalities (CA) over the Course of 17 Years.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Velcade (V)-Thalidomide (T)-Dexamethasone (D) for Advanced and Refractory Multiple Myeloma (MM): Long-Term Follow-Up of Phase I–II Trial UARK 2001-37: Superior Outcome in Patients with Normal Cytogenetics and No Prior T.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (52)
Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (0)